NDC 25021-236
topotecan
Topotecan
topotecan is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Topotecan Hydrochloride.
| Product ID | 25021-236_5c7ca55c-2902-41c6-930c-0335f809d0ee |
| NDC | 25021-236 |
| Product Type | Human Prescription Drug |
| Proprietary Name | topotecan |
| Generic Name | Topotecan |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-12-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022453 |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |